Immediate Impact
2 from Science/Nature 64 standout
Citing Papers
Fluorescent Probes for Disease Diagnosis
2024 Standout
Novel and emerging treatments for major depression
2022 Standout
Works of Gerri E. Schwartz being referenced
Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder
2003
Effects of Reboxetine on Anxiety, Agitation, and Insomnia: Results of a Pooled Evaluation of Randomized Clinical Trials
2002
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gerri E. Schwartz | 166 | 223 | 154 | 22 | 639 | |
| H. Tuynman-Qua | 132 | 305 | 173 | 18 | 680 | |
| Bonnie P. Taylor | 301 | 221 | 293 | 17 | 681 | |
| A. Tadić | 139 | 180 | 154 | 17 | 605 | |
| R. J. Ancill | 80 | 179 | 91 | 38 | 701 | |
| Ioannis Nimatoudis | 99 | 234 | 194 | 46 | 690 | |
| J. J. Fleminger | 118 | 370 | 308 | 21 | 735 | |
| Sirijit Suttajit | 134 | 344 | 99 | 38 | 639 | |
| Barbara Hawellek | 75 | 234 | 206 | 19 | 714 | |
| H. Edmund Pigott | 181 | 132 | 147 | 21 | 719 | |
| Annabel Walsh | 118 | 96 | 81 | 29 | 606 |
All Works
Loading papers...